BETA: Please send your feedback!
Neurotrope
NTRP:NAS
Medical Specialties
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Medical Specialties
Founded 2013
Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. It operates through the following geographical segments: US; European Union; Japan; and China and India. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on June 13, 2013 and is headquartered in New York, NY.
website
Headquarters
Executives
Name | Title | Gender |
Robert Weinstein, MBA, CPA | Chief Financial Officer, Secretary & Treasurer | Male |
Susanne Wilke, PhD, MBA | Chief Executive Officer & Director | Female |
Joshua N. Silverman | Chairman | Male |
Daniel Alkon, MD | President & Chief Scientific Officer | Male |
Mindful Investing Summary
Neurotrope - Competitors and Related Companies
How Neurotrope stacks up to its peers in the Medical Specialties industry or with competing business segments.
Neurotrope
NTRP:NAS
Medical Specialties
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…